Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acer Therapeutics Inc (NQ: ACER )

1.450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acer Therapeutics Inc

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
  
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Relief And Acer Therapeutics Secures Orphan Drug Designation From European Union For Metabolic Disorder Candidate
The European Commission has granted orphan medicinal product designation in the EU to Relief Therapeutics and Acer Therapeutics’ (NASDAQ: ACER) lead asset ACER-001 (sodium phenylbutyrate) for the... 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
 
Via Benzinga
FDA Accepts Acer's Inborn Metabolism Disorder Therapy Refiling For Review
The U.S. Food and Drug Administration (FDA) has accepted for review Acer Therapeutics’ (NASDAQ: ACER) resubmission of New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for oral suspension... 
Via Benzinga
Acer Therapeutics: Q1 Earnings Insights
Acer Therapeutics (NASDAQ:ACER) reported its Q1 earnings results on Monday, May 16, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
Via Benzinga
Here's Why Acer Therapeutics Shares Are Moving
Acer Therapeutics Inc (NASDAQ: ACER) shares are trading higher by 7.43% to $1.52 after the company and Relief Therapeutics announced the CNIPA issued a utility model patent covering dosage form claims... 
Via Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. 
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment. 
Via Benzinga
67 Biggest Movers From Yesterday
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital. 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
FDA Rejects Acer Therapeutics - Relief Therapeutics' Urea Cycle Disorder Candidate
 
Via Benzinga
Acer Therapeutics' Stock Down As FDA Rejects Inborn Metabolism Disorder (UCD) Candidate
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to Acer Therapeutics’ (NASDAQ: ACER) New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate)... 
Via Benzinga
95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... 
Via Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers Bird Global, Inc. (NASDAQ: BRDS) rose 26.3% to $1.24 in pre-market trading after the company posted strong Q1 sales. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million. 
Via Benzinga
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / May 6, 2022 / Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY)... 
From Relief Therapeutics Holdings AG
Via AccessWire
Exposures Product Safety
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / April 12, 2022 / Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA... 
From Relief Therapeutics Holdings AG
Via AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.